Brief: Bioxytran Expands Institutional Investor Base With $500,000 Equity Investment
12/06/2023 15:28
June 12 (Reuters) - Bioxytran Inc BIXT.PK :
* BIOXYTRAN EXPANDS INSTITUTIONAL INVESTOR BASE WITH AN
ADDITIONAL
$500,000 EQUITY INVESTMENT
Source text for Eikon: ID:nGNX8Gkpw7
Further company coverage: BIXT.PK
(reuters.briefs@thomsonreuters.com)
Recent news on Bioxytran
See all newsUS officials pressed China on rare earths, farm goods commitments, Bessent says (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran